Article
Performance of HIV-1 drug resistance testing at low-level viremia and its ability to predict future virologic outcomes and viral evolution in treatment-naive individuals.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 1 Apr 2014
Gonzalez-Serna A, Min J E, Woods C, Chan D, Lima V D, Montaner J S G, Harrigan P R, Swenson L C
Abstract excerpt
BACKGROUND: Low-level viremia (LLV; human immunodeficiency virus [HIV-1] RNA 50-999 copies/mL) occurs frequently in patients receiving antiretroviral therapy (ART), but there are few or no data available demonstrating that HIV-1 drug resistance testing at a plasma viral load (pVL) <1000 copies/mL provides potentially clinically useful information. Here, we assess the ability to perform resistance testing by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.